Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 20

1.

Development of cognitive enhancers based on inhibition of insulin-regulated aminopeptidase.

Chai SY, Yeatman HR, Parker MW, Ascher DB, Thompson PE, Mulvey HT, Albiston AL.

BMC Neurosci. 2008 Dec 3;9 Suppl 2:S14. doi: 10.1186/1471-2202-9-S2-S14. Review.

2.

Identification and development of specific inhibitors for insulin-regulated aminopeptidase as a new class of cognitive enhancers.

Albiston AL, Diwakarla S, Fernando RN, Mountford SJ, Yeatman HR, Morgan B, Pham V, Holien JK, Parker MW, Thompson PE, Chai SY.

Br J Pharmacol. 2011 Sep;164(1):37-47. doi: 10.1111/j.1476-5381.2011.01402.x. Review.

3.

The angiotensin IV/AT4 receptor.

Chai SY, Fernando R, Peck G, Ye SY, Mendelsohn FA, Jenkins TA, Albiston AL.

Cell Mol Life Sci. 2004 Nov;61(21):2728-37. Review.

PMID:
15549174
4.

Involvement of insulin-regulated aminopeptidase in the effects of the renin-angiotensin fragment angiotensin IV: a review.

Stragier B, De Bundel D, Sarre S, Smolders I, Vauquelin G, Dupont A, Michotte Y, Vanderheyden P.

Heart Fail Rev. 2008 Sep;13(3):321-37. Epub 2007 Nov 8. Review.

PMID:
17990104
5.

Therapeutic targeting of insulin-regulated aminopeptidase: heads and tails?

Albiston AL, Peck GR, Yeatman HR, Fernando R, Ye S, Chai SY.

Pharmacol Ther. 2007 Dec;116(3):417-27. Epub 2007 Aug 31. Review.

PMID:
17900701
6.

Targeting the insulin-regulated aminopeptidase/AT4 receptor for cognitive disorders.

Hallberg M.

Drug News Perspect. 2009 Apr;22(3):133-9. doi: 10.1358/dnp.2009.22.3.1325032. Review.

PMID:
19440555
7.

Alzheimer's, angiotensin IV and an aminopeptidase.

Albiston AL, Fernando R, Ye S, Peck GR, Chai SY.

Biol Pharm Bull. 2004 Jun;27(6):765-7. Review.

8.

AT4 receptor is insulin-regulated membrane aminopeptidase: potential mechanisms of memory enhancement.

Albiston AL, Mustafa T, McDowall SG, Mendelsohn FA, Lee J, Chai SY.

Trends Endocrinol Metab. 2003 Mar;14(2):72-7. Review.

PMID:
12591177
9.

Cognitive-enhancing effects of angiotensin IV.

Gard PR.

BMC Neurosci. 2008 Dec 3;9 Suppl 2:S15. doi: 10.1186/1471-2202-9-S2-S15. Review.

10.

Cellular targets for angiotensin II fragments: pharmacological and molecular evidence.

Vauquelin G, Michotte Y, Smolders I, Sarre S, Ebinger G, Dupont A, Vanderheyden P.

J Renin Angiotensin Aldosterone Syst. 2002 Dec;3(4):195-204. Review.

PMID:
12584663
11.

The insulin-regulated aminopeptidase: a companion and regulator of GLUT4.

Keller SR.

Front Biosci. 2003 May 1;8:s410-20. Review.

PMID:
12700100
12.

Ang II and Ang IV: unraveling the mechanism of action on synaptic plasticity, memory, and epilepsy.

De Bundel D, Smolders I, Vanderheyden P, Michotte Y.

CNS Neurosci Ther. 2008 Winter;14(4):315-39. doi: 10.1111/j.1755-5949.2008.00057.x. Review. Erratum in: CNS Neurosci Ther. 2009 Summer;15(2):206. Dosage error in article text.

PMID:
19040556
13.
14.

Participation of D 1-4 dopamine receptors in the pro-cognitive effects of angiotensin IV and des-Phe 6 angiotensin IV.

Braszko JJ.

Neurosci Biobehav Rev. 2010 Mar;34(3):343-50. doi: 10.1016/j.neubiorev.2009.08.001. Epub 2009 Aug 15. Review.

PMID:
19686774
15.

Angiotensin converting enzyme inhibitors as potential cognitive enhancing agents.

Domeney AM.

J Psychiatry Neurosci. 1994 Jan;19(1):46-50. Review.

16.

Cognitive enhancers (nootropics). Part 1: drugs interacting with receptors.

Froestl W, Muhs A, Pfeifer A.

J Alzheimers Dis. 2012;32(4):793-887. doi: 10.3233/JAD-2012-121186. Review.

PMID:
22886028
17.

Putative cognitive enhancers in preclinical models related to schizophrenia: the search for an elusive target.

Barak S, Weiner I.

Pharmacol Biochem Behav. 2011 Aug;99(2):164-89. doi: 10.1016/j.pbb.2011.03.011. Epub 2011 Mar 21. Review.

PMID:
21420999
18.

Bioactive angiotensin peptides.

Moeller I, Allen AM, Chai SY, Zhuo J, Mendelsohn FA.

J Hum Hypertens. 1998 May;12(5):289-93. Review.

PMID:
9655649
19.

Cognition enhancers between treating and doping the mind.

Lanni C, Lenzken SC, Pascale A, Del Vecchio I, Racchi M, Pistoia F, Govoni S.

Pharmacol Res. 2008 Mar;57(3):196-213. doi: 10.1016/j.phrs.2008.02.004. Epub 2008 Feb 15. Review.

PMID:
18353672
20.

The likelihood of cognitive enhancement.

Lynch G, Palmer LC, Gall CM.

Pharmacol Biochem Behav. 2011 Aug;99(2):116-29. doi: 10.1016/j.pbb.2010.12.024. Epub 2011 Jan 6. Review.

Items per page

Supplemental Content

Write to the Help Desk